Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 26, 2015
[Multidisciplinarity, education, and training in pediatric oncology-hematology]G Vassal, J Landman-Parker, A Baruchel, et al.Leukemia|December 16, 2006
Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in childrenM N Dufourg, J Landman-Parker, M F Auclerc, et al.Hemasphere|January 25, 2020
Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study GroupS Blais, H Boutroux, M Pasquet, et al.Cancer Epidemiology|June 9, 2018
Genetic polymorphisms of Th2 interleukins, history of asthma or eczema and childhood acute lymphoid leukaemia: Findings from the ESCALE study (SFCE)A Bonaventure, L Orsi, J Rudant, et al.British Journal of Haematology|August 19, 2024
Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic originM Gilton, H Fernandes, C Martinez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric OncologyC Coze, O Hartmann, J Michon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemiaG Michel, J Landman-Parker, M F Auclerc, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de MoelleG Michel, G Socié, F Gebhard, et al.Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.Pageof 17